Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
SenesTech, Inc. (SNES) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "COMMON STOCK PURCHASE WARRANT SENESTECH, INC.",
"SENESTECH, INC."
08/21/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/10/2023 8-K Quarterly results
Docs: "SenesTech Announces Second Quarter 2023 Financial Results"
05/11/2023 8-K Quarterly results
Docs: "SenesTech Announces First Quarter 2023 Financial Results"
04/24/2023 8-K Quarterly results
03/16/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "SenesTech Announces 2022 Financial Results"
01/05/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "EXECUTION VERSION"
12/20/2022 8-K Quarterly results
11/18/2022 8-K Quarterly results
11/15/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ...
Docs: "CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SENESTECH, INC.",
"Investors: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,"
10/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN, AS AMENDED",
"SENESTECH, INC. STOCK OPTION GRANT NOTICE AND OPTION AGREEMENT",
"ATTACHMENT I SENESTECH, INC. 2018 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT"
09/01/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
08/26/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Investors: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,"
08/11/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/29/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "SenesTech Announces Year-End 2021 Financial and Operational Results Product Sales up 123% as the Company Drives ContraPest® Deployment in New and Existing Market Verticals PHOENIX, Ariz., March 29, 2022 SenesTech, Inc. , the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest, announced today that revenues for 2021 more than doubled compared to last year as the Company accelerated penetration in existing markets and expanded into a number of new market verticals. Since the end of 2021, the Company has announced a number of key deployments in government applications, accelerating penetration as more cities and counties recognize the growing success of ContraPest through media reports and marketing efforts. Also notably..."
03/04/2022 8-K Quarterly results
01/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Title: Chief Strategy Officer Reports To: Ken Siegel Chief, Executive Officer Start Date: May 1, 2021; or earlier as may be mutually arranged Compensation: Base salary of $175,000 per annum, paid on a semi-monthly basis, subject to deductions for taxes and other withholdings as required by law or the policies of the Company. Pay dates are the fifteenth and end of each month. Bonus Program: For 2021 you will be entitled to a bonus of $75,000 which will be guaranteed subject only to achievement of mutually agreed non-financial components of your role . During the first 90 days of your employment you will work with the CEO to create a set of target metrics and goals and a corresponding base, commission and bonus structure for your role. This structure will be implemented for calendar year 202..."
11/10/2021 8-K Quarterly results
Docs: "SenesTech Announces 2021 Third Quarter Financial and Operational Results Revenue More Than Doubles from the Third Quarter in 2020 and up 14% Sequentially PHOENIX, Ariz., November 10, 2021 SenesTech, Inc. , the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest, announced today revenues for the third quarter of 2021 more than doubled compared to the same period a year ago, and are up 14% sequentially. Year-to-date nine-month revenues were also more than double the same period last year. The record quarterly and year-to-date results are being driven by growth in each of the Company’ s targeted market verticals of agribusiness, municipalities, zoos and sanctuaries, commercial applications, and direct to consumer. The Company has r..."
08/12/2021 8-K Quarterly results
Docs: "SenesTech Announces 2021 Second Quarter Financial and Operational Results Revenue Growth of 125% from the Second Quarter in 2020 and 82% Sequentially PHOENIX, Ariz., August XX, 2021 SenesTech, Inc. , the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest, announced today revenues for the second quarter of 2021 increased 125% from the same period a year ago, and are up 82% sequentially. Year to date, revenues have increased 130% from the same period last year. The growth is driven by continued adoption of ContraPest across its key market segments and continued strong growth in California, which recently enacted legislation restricting the use of the four major second generation anticoagulant rodenticides , creating market opport..."
06/25/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
03/25/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "SenesTech Announces Third Quarter 2020 Financial and Operational Results",
"Transcript of Conference Call to Review Earnings on November 11, 2020 (furnished herewith)",
"SenesTech Restructures Board for Commercial Growth --- Three Directors Added to the Board"
10/23/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities
08/12/2020 8-K Quarterly results
07/10/2020 8-K Quarterly results
05/15/2020 8-K Quarterly results
Docs: "SenesTech Announces First Quarter 2020 Financial and Operational Results"
04/24/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Opinion of Perkins Coie LLP",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of April 21, 2020, between SenesTech, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and ea..."
04/22/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "SenesTech Announces Pricing of $5.0 Million Public Offering Priced At-The-Market under Nasdaq Rules"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy